These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9701849)

  • 1. Immunotherapeutic approaches of rheumatic disorders.
    Houssiau FA; Lauwerys BR
    Acta Clin Belg; 1998 Jun; 53(3):155-61. PubMed ID: 9701849
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical immunology 2007].
    Behrens GM; Schmidt RE
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1404-6. PubMed ID: 17570090
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
    Maini RN; Elliott MJ; Charles PJ; Feldmann M
    Springer Semin Immunopathol; 1994; 16(2-3):327-36. PubMed ID: 7716713
    [No Abstract]   [Full Text] [Related]  

  • 4. [New treatments for rheumatoid arthritis].
    Girault V; Flipo RM
    Soins; 2004 Sep; (688):37-8. PubMed ID: 15515847
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunotherapy in rheumatoid arthritis; current status].
    Breedveld FC; van de Putte LB
    Ned Tijdschr Geneeskd; 1996 Jun; 140(24):1255-9. PubMed ID: 8700279
    [No Abstract]   [Full Text] [Related]  

  • 6. High titers of ADAbs in rheumatic disease patients undergoing anti-TNF therapy is not associated with lupus-like autoimmunity.
    Safran A; Perreau M; So A; Zufferey P
    Lupus; 2017 Dec; 26(14):1571-1572. PubMed ID: 28625078
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathophysiological role of cytokines in congestive heart failure.
    Blum A; Miller H
    Annu Rev Med; 2001; 52():15-27. PubMed ID: 11160765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on the editorial by Pisetsky.
    Aringer M; Steiner G; Graninger W; Smolen J
    Arthritis Rheum; 2001 Jul; 44(7):1721-2. PubMed ID: 11465728
    [No Abstract]   [Full Text] [Related]  

  • 9. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
    Dejica DI; Manea EM
    Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune Pitfalls of Anti-Tumor Necrosis Factor-Alpha Therapy.
    Roginić S; Jelić A; Stipić-Marković A; Marinko A; Artuković IN; Dušanka MK
    Isr Med Assoc J; 2015 Feb; 17(2):117-9. PubMed ID: 26223091
    [No Abstract]   [Full Text] [Related]  

  • 11. Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade.
    Redlich K; Schett G; Steiner G; Hayer S; Wagner EF; Smolen JS
    Arthritis Rheum; 2003 Dec; 48(12):3308-19. PubMed ID: 14673982
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic, prognostic and therapeutic aspects of systemic lupus erythematosus and rheumatoid arthritis.
    Weyand C
    Klin Wochenschr; 1990; 68 Suppl 21():55-63. PubMed ID: 2198390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma exchange in rheumatoid arthritis and systemic lupus erythematosus using the new Y-S sac system].
    Shiokawa J
    Ter Arkh; 1982; 54(6):49-54. PubMed ID: 7112419
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukins, interferon and rheumatic disease.
    Talal N
    Clin Rheum Dis; 1985 Dec; 11(3):633-44. PubMed ID: 2416506
    [No Abstract]   [Full Text] [Related]  

  • 16. [Redefining treatment of rheumatic arthritis with anti-cytokines].
    Gabay C; So A
    Rev Med Suisse; 2007 Mar; 3(103):715-7. PubMed ID: 17458148
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytokine inhibition as a strategy for treating systemic lupus erythematosus.
    Clark DN; Markham JL; Sloan CS; Poole BD
    Clin Immunol; 2013 Sep; 148(3):335-43. PubMed ID: 23200699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged thoracic-duct drainage in rheumatoid arthritis and systemic lupus erythematosus.
    Paulus HE; Machleder HI; Clements PJ; Nyman K; Levine S
    West J Med; 1979 Apr; 130(4):309-24. PubMed ID: 375588
    [No Abstract]   [Full Text] [Related]  

  • 19. The possible role of tumor necrosis factor (TNF) and its natural inhibitors, the soluble-TNF receptors, in autoimmune diseases.
    Aderka D; Engelmann H; Wysenbeek AJ; Levo Y
    Isr J Med Sci; 1992 Feb; 28(2):126-30. PubMed ID: 1313788
    [No Abstract]   [Full Text] [Related]  

  • 20. B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks?
    Stohl W; Looney RJ
    Clin Immunol; 2006 Oct; 121(1):1-12. PubMed ID: 16697258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.